Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 141


Detection of latent anthracycline-induced cardiotoxicity using left ventricular end-systolic wall stress-velocity of circumferential fiber-shortening relationship.

Mizuno R, Fujimoto S, Saito Y, Okamoto Y.

Heart Vessels. 2014 May;29(3):384-9. doi: 10.1007/s00380-013-0375-5. Epub 2013 Jun 19.


Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.

Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, Byth K, Stuart K, Clarke JL, Thomas L.

Eur J Cancer. 2013 Nov;49(16):3396-403. doi: 10.1016/j.ejca.2013.06.046. Epub 2013 Aug 9.


Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.

Moon TJ, Miyamoto SD, Younoszai AK, Landeck BF.

Cardiol Young. 2014 Oct;24(5):854-65. doi: 10.1017/S1047951113001182. Epub 2013 Sep 18.


Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.

Toro-Salazar OH, Gillan E, O'Loughlin MT, Burke GS, Ferranti J, Stainsby J, Liang B, Mazur W, Raman SV, Hor KN.

Circ Cardiovasc Imaging. 2013 Nov;6(6):873-80. doi: 10.1161/CIRCIMAGING.113.000798. Epub 2013 Oct 4.


Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.

Jordan JH, D'Agostino RB Jr, Hamilton CA, Vasu S, Hall ME, Kitzman DW, Thohan V, Lawrence JA, Ellis LR, Lash TL, Hundley WG.

Circ Cardiovasc Imaging. 2014 Nov;7(6):872-9. doi: 10.1161/CIRCIMAGING.114.002217. Epub 2014 Oct 1.


Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy.

Cheung YF, Hong WJ, Chan GC, Wong SJ, Ha SY.

Heart. 2010 Jul;96(14):1137-41. doi: 10.1136/hrt.2010.194118. Epub 2010 May 29.


Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.

Drafts BC, Twomley KM, D'Agostino R Jr, Lawrence J, Avis N, Ellis LR, Thohan V, Jordan J, Melin SA, Torti FM, Little WC, Hamilton CA, Hundley WG.

JACC Cardiovasc Imaging. 2013 Aug;6(8):877-85. doi: 10.1016/j.jcmg.2012.11.017. Epub 2013 May 1.


Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.

Dodos F, Halbsguth T, Erdmann E, Hoppe UC.

Clin Res Cardiol. 2008 May;97(5):318-26. doi: 10.1007/s00392-007-0633-6. Epub 2008 Jan 14.


Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.

Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M.

Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603. Epub 2012 Jun 28.


Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.

Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B.

J Cancer Surviv. 2012 Mar;6(1):95-101. doi: 10.1007/s11764-011-0186-6. Epub 2011 Jun 1.


Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.

Stoodley PW, Richards DA, Hui R, Boyd A, Harnett PR, Meikle SR, Clarke J, Thomas L.

Eur J Echocardiogr. 2011 Dec;12(12):945-52. doi: 10.1093/ejechocard/jer187. Epub 2011 Oct 1.


Early detection of anthracycline-induced cardiotoxicity using two-dimensional speckle tracking echocardiography.

Kang Y, Cheng L, Li L, Chen H, Sun M, Wei Z, Pan C, Shu X.

Cardiol J. 2013;20(6):592-9. doi: 10.5603/CJ.2013.0158.


[Early and late anthracycline-induced cardiotoxicity in childhood: non-invasive evaluation of contractility in 116 patients].

Agnoletti G, Bonazza A, Pennacchio M, Porta F, Arrighini A.

G Ital Cardiol. 1995 Oct;25(10):1295-305. Italian.


Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity.

Bountioukos M, Doorduijn JK, Roelandt JR, Vourvouri EC, Bax JJ, Schinkel AF, Kertai MD, Sonneveld P, Poldermans D.

Eur J Echocardiogr. 2003 Dec;4(4):300-5.


Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.

Sung RY, Huang GY, Shing MK, Oppenheimer SJ, Li CK, Li CK, Lau J, Yuen MP.

Int J Cardiol. 1997 Aug 8;60(3):239-48.


Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.

Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N.

Pediatr Blood Cancer. 2015 Jan;62(1):123-7. doi: 10.1002/pbc.25206. Epub 2014 Aug 30.


Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood.

Iarussi D, Galderisi M, Ratti G, Tedesco MA, Indolfi P, Casale F, Di Tullio MT, de Divitiis O, Iacono A.

Clin Cardiol. 2001 Oct;24(10):663-9.


Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.

Tan TC, Bouras S, Sawaya H, Sebag IA, Cohen V, Picard MH, Passeri J, Kuter I, Scherrer-Crosbie M.

J Am Soc Echocardiogr. 2015 May;28(5):509-14. doi: 10.1016/j.echo.2015.02.001. Epub 2015 Mar 13.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk